Growth Metrics

Erasca (ERAS) Other Accumulated Expenses (2020 - 2026)

Erasca posted quarterly Other Accumulated Expenses of $12.1 million for Q1 2026, up 2.31% year-on-year from $11.9 million in Q1 2025, and up 20.92% on a QoQ basis from $10.0 million in Q4 2025.

Erasca (ERAS) has 7 years of Other Accumulated Expenses data on file, last reported at $12.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Accumulated Expenses rose 2.31% year-over-year to $12.1 million; the trailing twelve-month figure through Mar 2026 stood at $12.1 million (up 2.31% YoY), and the FY2025 full-year result was $10.0 million, down 32.46% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $12.1 million, up from $10.0 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $14.9 million in Q4 2024 and bottomed at $182000.0 in Q1 2023.
  • The 5-year median for Other Accumulated Expenses is $10.8 million (2022), against an average of $9.4 million.
  • The widest annual swing landed in 2022, when Other Accumulated Expenses sank 63.66%; it then jumped 4980.77% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $11.5 million in 2022, then decreased by 23.6% to $8.8 million in 2023, then soared by 68.94% to $14.9 million in 2024, then slumped by 32.46% to $10.0 million in 2025, then grew by 20.92% to $12.1 million in 2026.
  • The last three Other Accumulated Expenses figures came in at $12.1 million (Q1 2026), $10.0 million (Q4 2025), and $11.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Erasca 4.21 Bn 3.97 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 12.15 Mn
Dec 31, 2025 10.05 Mn
Sep 30, 2025 11.16 Mn
Jun 30, 2025 14.37 Mn
Mar 31, 2025 11.87 Mn
Dec 31, 2024 14.87 Mn
Sep 30, 2024 14.23 Mn
Jun 30, 2024 11.04 Mn
Mar 31, 2024 9.25 Mn
Dec 31, 2023 8.80 Mn
Sep 30, 2023 9.56 Mn
Jun 30, 2023 9.20 Mn
Mar 31, 2023 182,000.00
Dec 31, 2022 11.52 Mn
Sep 30, 2022 355,000.00
Jun 30, 2022 10.76 Mn
Mar 31, 2022 266,000.00
Dec 31, 2021 8.96 Mn
Sep 30, 2021 977,000.00
Jun 30, 2021 575,000.00
Dec 31, 2020 140,000.00